Navigation Links
Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share
Date:12/19/2013

eived benefits of the proposed acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of Jazz Pharmaceuticals' ordinary shares could decline; and those other risks detailed under the caption "Risk Factors" and elsewhere in Jazz Pharmaceuticals'  and Gentium's U.S. Securities and Exchange Commission ("SEC") filings and reports, including in Jazz Pharmaceuticals' Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 and Gentium's Annual Report on Form 20-F for the year ended December 31, 2012, each of which is filed with the SEC, and future filings and reports by either company. Neither Jazz Pharmaceuticals nor Gentium undertakes any duty or obligation to update any forward-looking statements contained in this press release as a result of new information, future events or changes in its expectations.

Additional Information and Where to Find It
The tender offer for the outstanding shares of Gentium (including those shares represented by American Depositary Shares) referenced in this press release has not yet commenced.  This announcement is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell shares of Gentium, nor is it a substitute for the tender offer materials that Jazz Pharmaceuticals and its acquisition subsidiary will file with the SEC upon commencement of the tender offer.  At the time the tender offer is commenced, Jazz Pharmaceuticals and its acquisition subsidiary will file tender offer materials on Schedule TO, and Gentium will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with respect to the tender offer. The tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other tender offer documents) and the Solicitation/Recommendation Statement will contain important information.  Holders of shares of Gentium are urged to read these documen
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Educational Grant Awarded to Winner of Ferring Pharmaceuticals Inaugural Heart to Heart Video Contest
2. Prolong Pharmaceuticals Adds Industry Veteran Ronald Jubin To Executive Management Team
3. Avista Capital Partners Announces a Majority Investment in Vertical Pharmaceuticals and Trigen Laboratories
4. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
5. Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
6. Smithers Quality Assessments Expands Certification Services to Include Pharmaceuticals Industry
7. Partnerships, Appointments, New Products, Public Offerings, and Agreements - Research Report on Questcor Pharmaceuticals, Hologic, IDEXX, Endologix, and Healthways
8. AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data at Anesthesia Medical Conference
9. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
10. Rafarma Pharmaceuticals Announces a $1.2 Million Private Placement
11. AcelRx Pharmaceuticals Adds New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014 Yesterday, former ... (Moberg) medical device manufacturing facility. Rep. Kennedy and ... neurological monitors facilitate cutting-edge research in neurological disease ... and mental health advocate, Garen Staglin , ... to fostering fundamental changes that will radically accelerate ...
(Date:7/10/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... sale to Galderma of all rights to Restylane, Perlane, ... for $1.4 billion in cash, pursuant to the previously ... acquisition of Galderma. "We are pleased ... company that is firmly committed to the aesthetic dermatology ...
(Date:7/10/2014)... 2014  Decision Resources Group finds that while ... specialists are willing to prescribe Durata,s Dalvance (dalbavancin) ... as OPAT, approximately two-thirds of the respondents reported ... hospital inpatients. However, our findings indicate that nearly ... on OPAT following hospital discharge, and most are ...
Breaking Medicine Technology:Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
... 27 454 Life Sciences, a Roche,company, ... of Illinois,at Urbana-Champaign today announced that they ... wasps. Using the company,s Genome,Sequencer(TM) system, the ... wasps and correlated different expression patterns to ...
... Investigations," Says ... Dissenting Panel Member, ATLANTA, ... the relationship between mercury (thimerosal) in vaccines and,children,s brain functioning ... Sallie Bernard, Executive Director of,SafeMinds. "Early Thimerosal Exposure and ...
Cached Medicine Technology:454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps 2454 Sequencing(TM) in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasps 3Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds 2
(Date:7/11/2014)... Thompson HealthDay Reporter THURSDAY, ... with HIV who was thought to be cured by immediate ... detectable levels of the AIDS-causing virus in her bloodstream, disappointed ... 4 years old, had remained virus-free even though she stopped ... had hoped her remission would open the door to a ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The Europe Well ... market in Europe with analysis and revenue forecast. The well ... around $2.4 billion in 2013 to $3.4 billion by 2018, ... Browse through the TOC of the Europe Well Intervention Market ... This also provides a glimpse of the segmentation in the ...
(Date:7/11/2014)... News) -- Children who have emergency surgery on ... potentially even death than those who have weekday ... the Johns Hopkins researchers noted that the risk ... data on nearly 440,000 simple emergency surgeries that ... 22-year period. The surgeries are considered generally ...
(Date:7/11/2014)... According to a new market research ... Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, NFC, RFID), Application ... Transportation, Agriculture) & Geography - Global Trends & Forecasts ... Things market was worth $1029.5 Billion in 2013, and ... an estimated CAGR of 4.08% from 2014 to 2020. ...
(Date:7/11/2014)... PROVIDENCE, R.I. -- Researchers from The Miriam ... under age 65 have significantly higher rates of ... with mobility impairments were less likely to attempt ... quit-smoking treatments may not be sufficient for this ... online in advance of print in the ...
Breaking Medicine News(10 mins):Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 3Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Europe Well Intervention Services Market is Expected to Reach $3.4 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Miriam Hospital study examines smoking prevalence 2
... The Libyan Department of Relief and Humanitarian ... a significant capability for medical disaster response in ... experts from the American-based company BLU-MED Response Systems ... University where members of Libyan Aid erected the ...
... March 3 Sysmex America, Inc., a leading ... today announced the availability of the Sysmex WAM ... middleware user facilities across the U.S. Sysmex WAM ... tool for new Sysmex WAM users and as ...
... soles of their feet and the palms of their hands ... some types of chemotherapy. Patients, family members also can feel ... Both share a need for quick answers or more detailed ... or unexpected symptoms. , A new section of the ...
... Oxygen Community Welcomes New Leaders Known for Patient Advocacy, ... The Council for Quality Respiratory Care (CQRC), an alliance ... care for nearly one half of the 1.5 million ... for improved quality of life, today praised President Obama,s ...
... FRANKLIN, Mass., March 3 PLC Systems Inc. (OTC Bulletin ... the news wire its financial results for the fourth quarter ... on Thursday, March 12, 2009. The company plans to host ... ET on that same day. The call may be joined ...
... as Possible , ALEXANDRIA, Va., March 3 The ... to know that hospice delivers the highest quality care ... coping with life-limiting illness. A recent article carried by ... Greg Bluestein, 03/02/09) carries a misinformed quote from an ...
Cached Medicine News:Health News:Libyan Aid Tests 50-Bed BLU-MED Deployable Field Hospital 2Health News:Sysmex America Introduces On Demand Middleware Training Tool 2Health News:Walther Cancer Foundation grant funds new IU Simon Cancer Center Web site section 2Health News:Council for Quality Respiratory Care Applauds President Obama's Appointments of Governor Sebelius, DeParle to Lead Health Care Efforts 2Health News:NHPCO Comments on Misleading Quote in Associated Press Article and Provides Helpful Information 2
... from Medtronic is changing the way clinicians ... their Medtronic CareLink Monitor and a standard ... information from their home or while traveling. ... have the ability to review device data ...
... Innova 3100 lets you perform exams from ... one room. With no compromises. An ideal ... a wide range of cardiovascular and interventional ... suited for a variety of vascular and ...
... Service provides clinically valuable, device-derived information ... failure to help specialty physicians discern ... are stable or deteriorating. For example, ... a Medtronic InSync Sentry™ CRT-D system ...
... Arginine vasopressin (AVP), also known as Antidiurectic ... and is transported via exonal flow to ... release. AVP secretion is regulated by changes ... that respond to alterations in blood volume ...
Medicine Products: